Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†

Cited by (1,000)

Items 301–400 of 1,000

1. Metabolic Consequences of High-Fat Diet Are Attenuated by Suppression of HIF-1α
   Mi‐Kyung Shin, Luciano F. Drager, Qiaoling Yao, Shannon Bevans‐Fonti, Doo Young Yoo, Jonathan C. Jun, Susan M. Aja, Sanjay Bhanot, Vsevolod Y. Polotsky · 2012 · PLoS ONE
2. Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico
   Omar Ramos-López · 2015 · World Journal of Gastroenterology
3. Ubiquitin‐Specific Protease 4 Is an Endogenous Negative Regulator of Metabolic Dysfunctions in Nonalcoholic Fatty Liver Disease in Mice
   Yichao Zhao, Fang Wang, Lingchen Gao, Longwei Xu, Renyang Tong, Nan Lin, Yuanyuan Su, Yan Yang, Yu Gao, Jie He et al. · 2018 · Hepatology
4. The L‐α‐Lysophosphatidylinositol/G Protein–Coupled Receptor 55 System Induces the Development of Nonalcoholic Steatosis and Steatohepatitis
   Marcos F. Fondevila, Uxia Fernandez, María J. Gonzalez-Rellan, Natália da Silva Lima, Xabier Buqué, Águeda González‐Rodríguez, Cristina Alonso, Marta Iruarrizaga‐Lejarreta, Teresa C. Delgado, Marta Varela‐Rey et al. · 2020 · Hepatology
5. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice
   Sadatsugu Sakane, Hayato Hikita, Kumiko Shirai, Yuta Myojin, Youichi Sasaki, Shinnosuke Kudo, Kenji Fukumoto, Naoki Mizutani, Yuki Tahata, Yuki Makino et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
6. Alterations in the redox state and liver damage: Hints from the EASL Basic School of Hepatology
   Gianluca Tell, Carlo Vascotto, Claudio Tiribelli · 2012 · Journal of Hepatology
7. FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis
   Audrey Coilly, Christophe Desterke, Catherine Guettier, Didier Samuel, Franck Chiappini · 2019 · Scientific Reports
8. Hepatocyte Injury and Hepatic Stem Cell Niche in the Progression of Non-Alcoholic Steatohepatitis
   Diletta Overi, Guido Carpino, Antonio Franchitto, Paolo Onori, Eugenio Gaudio · 2020 · Cells
9. Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease
   Sara Heebøll · 2014 · World Journal of Hepatology
10. Regional Differences Between Perisynovial and Infrapatellar Adipose Tissue Depots and Their Response to Class II and Class III Obesity in Patients With Osteoarthritis
    Natalia S. Harasymowicz, Nick D. Clement, Asim Azfer, Richard Burnett, Donald McGovern Salter, Hamish Simpson · 2017 · Arthritis & Rheumatology
11. Mitochondria‐Mediated Pathogenesis and Therapeutics for Non‐Alcoholic Fatty Liver Disease
    Zheng Li, Yan Li, Huixia Zhang, Jianru Guo, Christopher Wai Kei Lam, Caiyun Wang, Wei Zhang · 2019 · Molecular Nutrition & Food Research
12. B Cell-Activating Factor is Associated With the Histological Severity of Nonalcoholic Fatty Liver Disease
    Miyake, Teruki, Abe, Masanori, Tokumoto, Yoshio, Hirooka, Masashi, Furukawa, Shinya, Kumagi, Teru, Hamada, Maho, Kawasaki, Keitarou, Tada, Fujimasa, Ueda, Teruhisa et al. · 2013 · Hepatology International
13. Silencing HIF-1α aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-α/ANGPTL4 singling pathway
    Yan He, Wenhui Yang, Lulu Gan, Shijie Liu, Qing Ni, Yunxia Bi, Tun Han, Qian Liu, Hongyan Chen, Yang Hu et al. · 2020 · Gastroenterología y Hepatología
14. Hepatocyte‐specific deletion of adipose triglyceride lipase (adipose triglyceride lipase/patatin‐like phospholipase domain containing 2) ameliorates dietary induced steatohepatitis in mice
    Claudia Daniela Fuchs, Richard Radun, Emmanuel Dauda Dixon, Veronika Mlitz, Gerald Timelthaler, Emina Halilbasic, Merima Herac, Johan W. Jonker, Onne A. H. O. Ronda, Matteo Tardelli et al. · 2021 · Hepatology
15. Oleanolic Acid Improves Obesity-Related Inflammation and Insulin Resistance by Regulating Macrophages Activation
    Wanqing Li, Hongxiang Zeng, Min Xu, Chenglong Huang, Linfen Tao, Jun Li, Ting Zhang, Hong Chen, Jing Xia, Chunli Li et al. · 2021 · Frontiers in Pharmacology
16. Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention
    Julia Otten, Caroline Mellberg, Mats Ryberg, S Sandberg, Joel Kullberg, Bernt Lindahl, Christel L. Larsson, Jon B. Hauksson, Tommy Olsson · 2016 · International Journal of Obesity
17. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis
    J. Bernadette Moore · 2019 · Proceedings of The Nutrition Society
18. Gestational bisphenol A exposure induces fatty liver development in male offspring mice through the inhibition of HNF1b and upregulation of PPARγ
    Zi Long, Junshu Fan, Guangyuan Wu, Xiyu Liu, Hao Wu, Jiangzheng Liu, Yao Chen, Shuhao Su, Xiaodong Cheng, Zhongrui Xu et al. · 2020 · Cell Biology and Toxicology
19. The role of the immune system in the pathogenesis of NAFLD and potential therapeutic impacts of mesenchymal stem cell-derived extracellular vesicles
    Zahra Moayedfard, Farnaz Sani, Ali Akbar Alizadeh, Kamran Bagheri Lankarani, Mohammad Zarei, Negar Azarpira · 2022 · Stem Cell Research & Therapy
20. Diosgenin attenuates non-alcoholic fatty liver disease in type 2 diabetes through regulating SIRT6-related fatty acid uptake
    Kexin Nie, Yang Gao, Shen Chen, Zhi Wang, Hongzhan Wang, Yueheng Tang, Hao Su, Fuer Lu, Hui Dong, Ke Fang · 2023 · Phytomedicine
21. Hepatic fibrosis: Targeting peroxisome proliferator-activated receptor alpha from mechanism to medicines
    Lijun Gong, Fang Wei, Frank J. Gonzalez, Guolin Li · 2023 · Hepatology
22. Rhodiola crenulata root ameliorates derangements of glucose and lipid metabolism in a rat model of the metabolic syndrome and type 2 diabetes
    Jianwei Wang, Xianglu Rong, Wenlong Li, Yifan Yang, Johji Yamahara, Yuhao Li · 2012 · Journal of Ethnopharmacology
23. An Overview of Mouse Models of Nonalcoholic Steatohepatitis: From Past to Present
    Ans Jacobs, Anne‐Sophie Warda, Jef Verbeek, David M Cassiman, Pieter Spincemaille · 2016 · Current Protocols in Mouse Biology
24. Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
    Eric Lawitz, Bal Raj Bhandari, Peter Jerome Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen-Chieh Chuang, Ryan S. Huss, Chuhan Chung, Robert P. Myers et al. · 2022 · Clinical Gastroenterology and Hepatology
25. Membrane phospholipid remodeling modulates nonalcoholic steatohepatitis progression by regulating mitochondrial homeostasis
    Ye Tian, Matthew J. Jellinek, Kritika Mehta, Sun Mi Seok, Shanny Hsuan Kuo, Wei Lu, Ruicheng Shi, Richard G. Lee, Gee W. Lau, Jongsook Kim Kemper et al. · 2023 · Hepatology
26. Diet-induced dyslipidemia leads to nonalcoholic fatty liver disease and oxidative stress in guinea pigs
    Pernille Tveden‐Nyborg, Malene M. Birck, David Højland Ipsen, Tina Thiessen, Linda de Bie Feldmann, Maiken Marie Lindblad, Henrik Elvang Jensen, Jens Lykkesfeldt · 2015 · Translational research
27. Advances in Pediatric Nonalcoholic Fatty Liver Disease
    Ali Mencin, Joel E. Lavine · 2011 · Pediatric Clinics of North America
28. Prevention and reversal of hepatic steatosis with a high-protein diet in mice
    Sonia Garcia‐Caraballo, Tine M. Comhair, Fons Verheyen, Ingrid C. Gaemers, Frank G. Schaap, Sander M. Houten, Theodorus B. M. Hakvoort, Cornelis H.C. Dejong, Wouter H. Lamers, Eleonore S Köhler · 2013 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
29. Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus
    Hyo Jung Cho, Sun Hyuk Hwang, Jong Ik Park, Min Jae Yang, Jae Chul Hwang, Byung Moo Yoo, Kee Myung Lee, Sung Jae Shin, Kwang Jae Lee, Jin Hong Kim et al. · 2019 · Gut and Liver
30. Nutraceutical Properties of Polyphenols against Liver Diseases
    Jorge Simón, María Casado-Andrés, Naroa Goikoetxea‐Usandizaga, Marina Serrano‐Maciá, Maria Luz Martínez‐Chantar · 2020 · Nutrients
31. Translational approaches: from fatty liver to non-alcoholic steatohepatitis.
    Natalia Rosso, Norberto Carlos Chávez-Tapia, Claudio Tiribelli, Stefano Bellentani · 2014 · PubMed Central
32. Oleanolic acid supplement attenuates liquid fructose-induced adipose tissue insulin resistance through the insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt signaling pathway in rats
    Ying Li, Jianwei Wang, Tieguang Gu, Johji Yamahara, Yuhao Li · 2014 · Toxicology and Applied Pharmacology
33. The Hepatotoxicity of Palmitic Acid in Zebrafish Involves the Intestinal Microbiota
    Qianwen Ding, Zhen Zhang, Chao Ran, Suxu He, Yalin Yang, Zhen‐Yu Du, Jinxiong Zhang, Zhigang Zhou · 2018 · Journal of Nutrition
34. Visceral-to-Subcutaneous Abdominal Fat Ratio Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis
    Chan‐Hee Jung, Eun‐Jung Rhee, Hyemi Kwon, Yoosoo Chang, Seungho Ryu, Won‐Young Lee · 2020 · Endocrinology and Metabolism
35. Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials
    Carine Beysen, Patricia E. Schroeder, Eric Wu, Julie A. Brevard, Maria D. Ribadeneira, Wei Lu, Kiran Dole, Terry E. O’Reilly, Linda Morrow, Marcus Hompesch et al. · 2020 · Diabetes Obesity and Metabolism
36. E2F8 promotes hepatic steatosis through FABP3 expression in diet-induced obesity in zebrafish
    Yasuhito Shimada, Shisei Kuninaga, Michiko Ariyoshi, Beibei Zhang, Yasuhiko Shiina, Yoshinori Takahashi, Noriko Umemoto, Yuhei Nishimura, Hiroyuki Enari, Toshio Tanaka · 2015 · Nutrition & Metabolism
37. Lack of Efficacy of an Inhibitor of PDE4 in Phase 1 and 2 Trials of Patients With Nonalcoholic Steatohepatitis
    Vlad Ratziu, Pierre Bédossa, Sven Francque, Dominique G. Larrey, Guruprasad Padur Aithal, Lawrence Serfaty, M Voiculescu, Liliana Preoțescu, Frederik Nevens, Victor de Lédinghen et al. · 2014 · Clinical Gastroenterology and Hepatology
38. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1
    Guoyi Wu, Chen Rui, Ji-qiao Chen, Eiketsu Sho, Shanshan Zhan, Xianwen Yuan, Yi-tao Ding · 2017 · Cellular Physiology and Biochemistry
39. Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
    Anja Hess, Stefan D. Gentile, Amel Ben Saad, Raza‐Ur Rahman, Tim Habboub, Daniel Stephan Pratt, Alan C. Mullen · 2023 · The EMBO Journal
40. Nonalcoholic steatohepatitis in nonalcoholic fatty liver disease patients of Bangladesh
    Shahinul Alam · 2013 · World Journal of Hepatology
41. Iron overload causes oxidative stress and impaired insulin signaling in AML-12 hepatocytes
    D. J. Messner, B. Rhieu, K. Kowdley · 2013 · Digestive Diseases and Sciences
42. Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways
    Richard Skoien, Michelle M. Richardson, Julie R. Jonsson, Elizabeth Ellen Powell, Elizabeth M. Brunt, Brent A. Neuschwander‐Tetri, Prithi S. Bhathal, John B. Dixon, Paul E. O’Brien, Herbert Tilg et al. · 2013 · Liver International
43. Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1‐Dependent Mechanism During Hepatocyte Lipotoxicity
    Kyoko Tomita, Ayano Kabashima, Brittany L. Freeman, Steven F. Bronk, Petra Hirsova, Samar H. Ibrahim · 2017 · Journal of Cellular Biochemistry
44. Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet
    Liliana Felicia Iannucci, Federica Cioffi, Rosalba Senese, Fernando Goglia, Antonia Lanni, Paul M. Yen, Rohit A. Sinha · 2017 · Scientific Reports
45. Human-based systems: Mechanistic NASH modelling just around the corner?
    Joost Boeckmans, Alessandra Natale, Karolien Buyl, Vera Rogiers, Joery De Kock, Tamara Vanhaecke, Robim Marcelino Rodrigues · 2018 · Pharmacological Research
46. The Gut Microbiota and Its Metabolites, Novel Targets for Treating and Preventing Non‐Alcoholic Fatty Liver Disease
    Yinhua Ni, Liyang Ni, Fen Zhuge, Zhengwei Fu · 2020 · Molecular Nutrition & Food Research
47. SREBP‐2: A link between insulin resistance, hepatic cholesterol, and inflammation in NASH
    Derrick M. Van Rooyen, Geoff C. Farrell · 2011 · Journal of Gastroenterology and Hepatology
48. Lysosomal cholesterol overload in macrophages promotes liver fibrosis in a mouse model of NASH
    Michiko Itoh, Atsushi Tamura, S KANAI, Miyako Tanaka, Yohei Kanamori, Ibuki Shirakawa, Ayaka Ito, Yasuyoshi Oka, Isao Hidaka, Taro Takami et al. · 2023 · The Journal of Experimental Medicine
49. Dietary trans‐Fatty Acid Induced NASH is Normalized Following Loss of trans‐Fatty Acids from Hepatic Lipid Pools
    Brent A. Neuschwander‐Tetri, David A. Ford, Sahaja Acharya, George D. Gilkey, Metin Başaranoğlu, Laura Hope Tetri, Elizabeth M. Brunt · 2012 · Lipids
50. Lipidomic Profiling Reveals Disruption of Lipid Metabolism in Valproic Acid-Induced Hepatotoxicity
    Shansen Xu, Yanan Chen, Yiyi Ma, Ting Liu, Mingming Zhao, Zhan‐You Wang, Limei Zhao · 2019 · Frontiers in Pharmacology
51. Drug discovery and treatment paradigms in nonalcoholic steatohepatitis
    Mazen Noureddin, Mark Dhinesh Muthiah, Arun Jayant Sanyal · 2019 · Endocrinology Diabetes & Metabolism
52. Growth arrest and DNA damage-inducible 45α protects against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet
    Naoki Tanaka, Shogo Takahashi, Xiao Hu, Lu Yu, Naoyuki Fujimori, Srujana Golla, Zhong‐Ze Fang, Toshifumi Aoyama, Kristopher W. Krausz, Frank J. Gonzalez · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
53. Astragaloside IV Improves High-Fat Diet–Induced Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Rats by Regulating Inflammatory Factors Level via TLR4/NF-κB Signaling Pathway
    Yingli Liu, Qiu-Zan Zhang, Yan-Rong Wang, Lina Fu, Jingshu Han, Jing Zhang, Bangmao Wang · 2021 · Frontiers in Pharmacology
54. p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
    Chong Teik Tan, Natalie Jun Hui Soh, Hao‐Chun Chang, Victor Chun Kong Yu · 2021 · FEBS Journal
55. A Lipidomic Readout of Disease Progression in A Diet-Induced Mouse Model of Nonalcoholic Fatty Liver Disease.
    Arun Jayant Sanyal, Tommy Pacana · 2015 · Europe PMC (PubMed Central)
56. Current and emerging pharmacological therapy for non-alcoholic fatty liver disease
    Ahad Eshraghian · 2017 · World Journal of Gastroenterology
57. Catalpol induces autophagy and attenuates liver steatosis in ob/ob and high-fat diet-induced obese mice
    Huihui Ren, Dan Wang, Lu Zhang, Xiaonang Kang, Yaling Li, Xinrong Zhou, Gang Yuan · 2019 · Aging
58. Too Much of a Good Thing? An Evolutionary Theory to Explain the Role of Ceramides in NAFLD
    Annelise M. Poss, Scott A. Summers · 2020 · Frontiers in Endocrinology
59. Fatty Acids Activate the Transcriptional Coactivator YAP1 to Promote Liver Fibrosis via p38 Mitogen-Activated Protein Kinase
    Shadi Salloum, Andre J. Jeyarajan, Annie J. Kruger, Jacinta Alison Holmes, Tuo Shao, Mozhdeh Sojoodi, Myung‐Ho Kim, Zhu Zhuo, Stuti G. Shroff, Andrew P. Kassa et al. · 2021 · Cellular and Molecular Gastroenterology and Hepatology
60. Integrated bioinformatics and multiomics reveal Liupao tea extract alleviating NAFLD via regulating hepatic lipid metabolism and gut microbiota
    Shanyi Yang, Zhijuan Wei, Jichu Luo, Xuancheng Wang, Guanghui Chen, Xuan Guan, Zhiyong She, Wenhui Liu, Ying Tong, Huan Liu et al. · 2024 · Phytomedicine
61. Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025
    Jennifer A. Panganiban, Mohit Kehar, Samar H. Ibrahim, Phillipp Hartmann, Shilpa Sood, Sara Mohammed Hassan, Charina M. Ramirez, Rohit Kohli, Marisa Censani, Erin E. Mauney et al. · 2025 · Obesity Pillars
62. Ezetimibe: Its Novel Effects on the Prevention and the Treatment of Cholesterol Gallstones and Nonalcoholic Fatty Liver Disease
    Ornella de Bari, Brent A. Neuschwander‐Tetri, Min Liu, Piero Portincasa, David Q.‐H. Wang · 2011 · Journal of Lipids
63. Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver
    Nathan C. Winn, Thomas J. Jurrissen, Zachary Ian Grunewald, Rory P. Cunningham, Makenzie L. Woodford, Jill A. Kanaley, Dennis B. Lubahn, Camila Manrique‐Acevedo, R. Scott Rector, Victoria J. Vieira‐Potter et al. · 2018 · American Journal of Physiology-Endocrinology and Metabolism
64. Permethrin and ivermectin modulate lipid metabolism in steatosis-induced HepG2 hepatocyte
    Jason Szuhao Yang, Weipeng Qi, Renalison Farias‐Pereira, Stephanie H. Choi, John Marshall Clark, Daeyoung Kim, Yeonhwa Park · 2019 · Food and Chemical Toxicology
65. Characterizing the composition, metabolism and physiological functions of the fatty liver in Rana omeimontis tadpoles
    Wei Zhu, Meihua Zhang, Liming Chang, Wenbo Zhu, Cheng Li, Feng Xie, Huan Zhang, Tian Zhao, Jianping Jiang · 2019 · Frontiers in Zoology
66. Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
    Haider Ghazanfar, Nismat Javed, Abeer Qasim, George Sarin Zacharia, Ali Ghazanfar, Abhilasha Jyala, Elona Shehi, Harish Patel · 2024 · Cancers
67. High fat diet-induced modifications in membrane lipid and mitochondrial-membrane protein signatures precede the development of hepatic insulin resistance in mice
    Melanie Kahle, Alexander Schäfer, Anett Seelig, Jürgen Schultheiß, Moya Wu, Michaela Aichler, Jörn Leonhardt, Birgit Rathkolb, Jan Rozman, Hakan Sarioglu et al. · 2014 · Molecular Metabolism
68. Strategies for the early detection of drug-induced hepatic steatosis in preclinical drug safety evaluation studies
    David E. Amacher · 2010 · Toxicology
69. Exercise improves adipose function and inflammation and ameliorates fatty liver disease in obese diabetic mice
    Fahrettin Haczeyni, Vanessa Barn, Auvro R. Mridha, Matthew M. Yeh, Emma Estévez, Mark Anthony Febbraio, Christopher James Nolan, Kim S. Bell-Anderson, Narci Teoh, Geoffrey C. Farrell · 2015 · Obesity
70. Screening for the efficacy on lipid accumulation in 3T3-L1 cells is an effective tool for the identification of new anti-diabetic compounds
    Xiao‐Yi Zeng, Xiu Zhou, Jun Xu, Stanley M. H. Chan, Charlie Changli Xue, Juan Carlos Molero, Ji‐Ming Ye · 2012 · Biochemical Pharmacology
71. Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice: Role of PPARγ
    Jinbiao Chen, Wei Wang, Yanfei Qi, Dominik C. Kaczorowski, Geoffrey William McCaughan, Jennifer R. Gamble, Anthony Simon Don, Xin Gao, Mathew Alexander Vadas, Pu Xia · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
72. Theacrine protects against nonalcoholic fatty liver disease by regulating acylcarnitine metabolism
    Guo-En Wang, Yi-Fang Li, Yu-Jia Zhai, Lian Gong, Jingyu Tian, Mo Hong, Nan Yao, Yanping Wu, Hiroshi Kurihara, Rong‐Rong He · 2018 · Metabolism
73. Obstructive Sleep Apnea and the Liver
    Malav P. Parikh, Niyati M. Gupta, Arthur J. McCullough · 2019 · Clinics in Liver Disease
74. FXR-mediated inhibition of autophagy contributes to FA-induced TG accumulation and accordingly reduces FA-induced lipotoxicity
    Kun Wu, Tao Zhao, Christer Högstrand, Yi-Chuang Xu, Shi-Cheng Ling, Guang‐Hui Chen, Zhi Luo · 2020 · Cell Communication and Signaling
75. Group 3 innate lymphoid cells protect steatohepatitis from high-fat diet induced toxicity
    Hamaguchi, Masahide, Okamura, Takuro, Fukuda, Takuya, Nishida, Kensuke, Yoshimura, Yuta, Hashimoto, Yoshitaka, Ushigome, Emi, Nakanishi, Naoko, Majima, Saori, Asano, Mai et al. · 2021 · Frontiers in Immunology
76. GLP‐1 receptor agonists: effects on the progression of non‐alcoholic fatty liver disease
    Liu, Jia, Wang, Guang, Jia, Yumei, Xu, Yuan · 2015 · Diabetes/Metabolism Research and Reviews
77. Tauroursodeoxycholic Acid Attenuates Progression of Steatohepatitis in Mice Fed a Methionine–Choline-Deficient Diet
    Eun Ju Cho, Jung‐Hwan Yoon, Min‐Sun Kwak, Eun Sun Jang, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Chung Yong Kim, Hyo-Suk Lee · 2014 · Digestive Diseases and Sciences
78. Lipid Metabolism, Oxidative Stress and Cell Death Are Regulated by PKC Delta in a Dietary Model of Nonalcoholic Steatohepatitis
    Michael W. Greene, Christine M. Burrington, Darin T. Lynch, Samantha K. Davenport, Andrew K. Johnson, Melissa J. Horsman, Saleem Chowdhry, Jian Zhang, Janet D. Sparks, Paul C. Tirrell · 2014 · PLoS ONE
79. Non-Alcoholic Steatohepatitis: New Insights from OMICS Studies
    C. Martel, Davide Degli Esposti, Antonin Bouchet, Catherine Brenner, Antoinette Lemoine · 2012 · Current Pharmaceutical Biotechnology
80. Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models
    Franck Chiappini, Christophe Desterke, Justine Bertrand‐Michel, Catherine Guettier, François Le Naour · 2016 · Scientific Reports
81. An Overview of Novel Dietary Supplements and Food Ingredients in Patients with Metabolic Syndrome and Non-Alcoholic Fatty Liver Disease
    Priscila Silva Figueiredo, Aline Carla Inada, Melina Ribeiro Fernandes, Daniela Granja Arakaki, Karine de Cássia Freitas, Rita de Cássia Avellaneda Guimarães, Valter Aragão do Nascimento, Priscila Aiko Hiane · 2018 · Molecules
82. Hexanoic, Octanoic and Decanoic Acids Promote Basal and Insulin-Induced Phosphorylation of the Akt-mTOR Axis and a Balanced Lipid Metabolism in the HepG2 Hepatoma Cell Line
    Sabri Ahmed Rial, Gaétan Ravaut, Tommy Malaret, Karl‐F. Bergeron, Cathérine Mounier · 2018 · Molecules
83. Coordinated changes of gut microbiome and lipidome differentiates nonalcoholic steatohepatitis (NASH) from isolated steatosis
    Minyi Qian, Hai Hu, Ying Yao, Danyang Zhao, Shilei Wang, Chuyue Pan, Xubin Duan, Yingsheng Gao, Jun Liu, Yufei Zhang et al. · 2019 · Liver International
84. Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis
    Kunimaro Furuta, Qian-Qian Guo, P. Hirsova, S. Ibrahim · 2020 · Biology
85. Adenosine A2a receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats
    Chiara Imarisio, Elisa Alchera, Salvatore Sutti, Guido Valente, Francesca Boccafoschi, Emanuele Albano, Rita Carini · 2012 · Clinical Science
86. Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation
    Maria Embgenbroich, Hendrik J.P. van der Zande, Leonie Hussaarts, Jonas Schulte-Schrepping, Leonard R. Pelgrom, Noemí García‐Tardón, Laura Schlautmann, Isabel Stötzel, Kristian Händler, Joost M. Lambooij et al. · 2021 · Proceedings of the National Academy of Sciences
87. Targeting oxidized phospholipids by AAV-based gene therapy in mice with established hepatic steatosis prevents progression to fibrosis
    Clint M. Upchurch, Scott Yeudall, Caitlin M. Pavelec, Dennis Merk, Jan Greulich, Mohan C. Manjegowda, Shyam S. Raghavan, Irina M. Bochkis, Michael M. Scott, Edward Perez‐Reyes et al. · 2022 · Science Advances
88. MRG15 aggravates non-alcoholic steatohepatitis progression by regulating the mitochondrial proteolytic degradation of TUFM
    Cheng Tian, Xuewen Min, Yongxu Zhao, Yuchen Wang, Xiaoshan Wu, Situn Liu, Wei Dou, Tingting Zhou, Yan Liu, Rongkui Luo et al. · 2022 · Journal of Hepatology
89. Liver Perilipin 5 Expression Worsens Hepatosteatosis But Not Insulin Resistance in High Fat-Fed Mice
    Michelle B. Trevino, David J. Mazur-Hart, Yui Machida, Timothy King, Joseph Nadler, Elena Galkina, Arjun Poddar, Sucharita M. Dutta, Yumi Imai · 2015 · Molecular Endocrinology
90. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis
    Ming-xia Liu, Man Gao, Chun-zhu Li, Cunzhi Yu, Hong Yan, Chun Peng, Yu Li, Chenggang Li, Ze-long Ma, Yang Zhao et al. · 2017 · Acta Pharmacologica Sinica
91. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease
    Gregory H. Norris, Christopher N. Blesso · 2017 · Nutrition Reviews
92. Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance
    Hye Young Kim, So Y. Park, Mi H. Lee, Jee Hyun Rho, Yoo J. Oh, Hye Uk Jung, Seung H. Yoo, Na Young Jeong, Hye J. Lee, Sunghwan Suh et al. · 2015 · Journal of Hepatology
93. Obeticholic acid improves adipose morphometry and inflammation and reduces steatosis in dietary but not metabolic obesity in mice
    Fahrettin Haczeyni, Laurence Poekes, Hans Wang, Auvro R. Mridha, Vanessa Barn, W. Geoffrey Haigh, George N. Ioannou, Matthew M. Yeh, Isabelle Anne Leclercq, Narcissus Teoh et al. · 2016 · Obesity
94. Metabolically healthy versus unhealthy obesity and risk of fibrosis progression in non‐alcoholic fatty liver disease
    Yejin Kim, Yoosoo Chang, Yong Kyun Cho, Jiin Ahn, Ho Cheol Shin, Seungho Ryu · 2019 · Liver International
95. FABP4 in LSECs promotes CXCL10-mediated macrophage recruitment and M1 polarization during NAFLD progression
    Cui Zhou, Zhenyang Shen, Bo Shen, Weiming Dai, Zhongsang Sun, Yuecheng Guo, Xianjun Xu, Junjun Wang, Jingyi Lu, Qingqing Zhang et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
96. High-protein diets prevent steatosis and induce hepatic accumulation of monomethyl branched-chain fatty acids
    Sonia Garcia‐Caraballo, Tine M. Comhair, Sander M. Houten, Cornelis H.C. Dejong, Wouter H. Lamers, Eleonore S Köhler · 2014 · The Journal of Nutritional Biochemistry
97. Dietary cholesterol, female gender and n-3 fatty acid deficiency are more important factors in the development of non-alcoholic fatty liver disease than the saturation index of the fat
    Tine M. Comhair, Sonia Garcia‐Caraballo, Cornelis H.C. Dejong, Wouter H. Lamers, Eleonore S Köhler · 2011 · Nutrition & Metabolism
98. Natural History of NAFLD
    Raluca Pais, Thomas Maurel · 2021 · Journal of Clinical Medicine
99. Immune-metabolic interactions in homeostasis and the progression to NASH.
    J. Hoogerland, B. Staels, D. Dombrowicz · 2022 · Trends in endocrinology and metabolism
100. Salvia miltiorrhiza extract may exert an anti-obesity effect in rats with high-fat diet-induced obesity by modulating gut microbiome and lipid metabolism
     Zi-Li Ai, Xian Zhang, Wei Ge, Youbao Zhong, Hai-Yan Wang, Zheng-Yun Zuo, Duan‐Yong Liu · 2022 · World Journal of Gastroenterology